Careers  |  Sign In  |  Register

FDA Panel Backs Implantable Lens to Correct Vision

Staar Surgical Co said an independent advisory panel to the FDA recommended marketing approval for its implantable lens, bringing it closer to a long-awaited U.S. launch and sending the company’s shares up 27 percent,” according to an article published by Reuters. The Visian Toric implantable lens “can correct both nearsightedness and blurry vision associated with astigmatism.” Analysts “expect regulatory approval for the lens in the second half of 2014, adding that “the positive FDA panel is the first of several important milestones on the horizon for Staar.”

Read the article from Reuters.